Welcome to our dedicated page for Coeptis Therapeutics Holdings SEC filings (Ticker: ZSQR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Coeptis Therapeutics Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Coeptis Therapeutics Holdings's regulatory disclosures and financial reporting.
BSG Series CM, LLC has filed a Schedule 13D reporting control of Z Squared Inc. common stock. It beneficially owns 41,521,276 shares, or about 80.73% of the outstanding 51,431,493 shares as of April 24, 2026, obtained as stock consideration in a merger involving Z Squared Opco, Inc.
The reporting person plans to distribute all or substantially all of these shares to its members over time, but sales of the shares are tightly restricted. Lock-up and leak-out terms limit monthly sale volumes, require the stock to trade above specific price thresholds, and cap sales relative to recent average trading volume.
BSG Series CM, LLC has filed a Schedule 13D reporting control of Z Squared Inc. common stock. It beneficially owns 41,521,276 shares, or about 80.73% of the outstanding 51,431,493 shares as of April 24, 2026, obtained as stock consideration in a merger involving Z Squared Opco, Inc.
The reporting person plans to distribute all or substantially all of these shares to its members over time, but sales of the shares are tightly restricted. Lock-up and leak-out terms limit monthly sale volumes, require the stock to trade above specific price thresholds, and cap sales relative to recent average trading volume.
BSG Series CM, LLC has filed an initial ownership report for Z Squared Inc. common stock. The Form 3 shows BSG Series CM, LLC as a ten percent owner, with direct beneficial ownership of 41,521,276 shares of common stock, par value $0.0001 per share, as of April 24, 2026. The filing does not report any recent purchases or sales, only the existing holding.
BSG Series CM, LLC has filed an initial ownership report for Z Squared Inc. common stock. The Form 3 shows BSG Series CM, LLC as a ten percent owner, with direct beneficial ownership of 41,521,276 shares of common stock, par value $0.0001 per share, as of April 24, 2026. The filing does not report any recent purchases or sales, only the existing holding.